TY - JOUR AU - Arnason, J. E. AU - Brown, J. R. PY - 2015 DA - 2015// TI - Targeted therapy for chronic lymphocytic leukemia: current status and future directions JO - Drugs VL - 75 UR - https://doi.org/10.1007/s40265-014-0338-x DO - 10.1007/s40265-014-0338-x ID - Arnason2015 ER - TY - JOUR AU - Rossi, J. F. PY - 2015 DA - 2015// TI - Targeted therapies in adult B-cell malignancies JO - Biomed Res Int VL - 2015 ID - Rossi2015 ER - TY - JOUR AU - Finn, O. J. PY - 2003 DA - 2003// TI - Cancer vaccines: between the idea and the reality JO - Nat Rev Immunol VL - 3 UR - https://doi.org/10.1038/nri1150 DO - 10.1038/nri1150 ID - Finn2003 ER - TY - JOUR AU - Naddafi, F. AU - Davami, F. PY - 2015 DA - 2015// TI - Anti-CD19 monoclonal antibodies: a new approach to lymphoma therapy JO - Int J Mol Cell Med VL - 4 ID - Naddafi2015 ER - TY - JOUR AU - Bird, A. P. PY - 1986 DA - 1986// TI - CpG-rich islands and the function of DNA methylation JO - Nature VL - 321 UR - https://doi.org/10.1038/321209a0 DO - 10.1038/321209a0 ID - Bird1986 ER - TY - JOUR AU - Berges, C. AU - Haberstock, H. AU - Fuchs, D. AU - Miltz, M. AU - Sadeghi, M. AU - Opelz, G. PY - 2008 DA - 2008// TI - Proteasome inhibition suppresses essential immune functions of human CD4+ T cells JO - Immunology VL - 124 UR - https://doi.org/10.1111/j.1365-2567.2007.02761.x DO - 10.1111/j.1365-2567.2007.02761.x ID - Berges2008 ER - TY - JOUR AU - Paolo, J. A. AU - Huang, T. AU - Balazs, M. AU - Barbosa, J. AU - Barck, K. H. AU - Bravo, B. J. PY - 2011 DA - 2011// TI - Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis JO - Nat Chem Biol VL - 7 UR - https://doi.org/10.1038/nchembio.481 DO - 10.1038/nchembio.481 ID - Paolo2011 ER - TY - JOUR AU - Zappasodi, R. AU - Braud, F. AU - Nicola, M. PY - 2015 DA - 2015// TI - Lymphoma immunotherapy: current status JO - Front Immunol VL - 6 UR - https://doi.org/10.3389/fimmu.2015.00448 DO - 10.3389/fimmu.2015.00448 ID - Zappasodi2015 ER - TY - JOUR AU - Lorentzen, C. L. AU - Straten, P. T. PY - 2015 DA - 2015// TI - CD19-chimeric antigen receptor t cells for treatment of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia JO - Scand J Immunol VL - 82 UR - https://doi.org/10.1111/sji.12331 DO - 10.1111/sji.12331 ID - Lorentzen2015 ER - TY - JOUR AU - Chiron, D. AU - Bekeredjian-Ding, I. AU - Pellat-Deceunynck, C. AU - Bataille, R. AU - Jego, G. PY - 2008 DA - 2008// TI - Toll-like receptors: lessons to learn from normal and malignant human B cells JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2008-02-140673 DO - 10.1182/blood-2008-02-140673 ID - Chiron2008 ER - TY - JOUR AU - Jahrsdörfer, B. AU - Hartmann, G. AU - Racila, E. AU - Jackson, W. AU - Mühlenhoff, L. AU - Meinhardt, G. PY - 2001 DA - 2001// TI - CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens JO - J Leukoc Biol VL - 69 ID - Jahrsdörfer2001 ER - TY - JOUR AU - Agrawal, S. AU - Gupta, S. PY - 2011 DA - 2011// TI - TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors JO - J Clin Immunol VL - 31 UR - https://doi.org/10.1007/s10875-010-9456-8 DO - 10.1007/s10875-010-9456-8 ID - Agrawal2011 ER - TY - JOUR AU - Sabroe, I. AU - Parker, L. C. AU - Dower, S. K. AU - Whyte, M. K. B. PY - 2008 DA - 2008// TI - The role of TLR activation in inflammation JO - J Pathol VL - 214 UR - https://doi.org/10.1002/path.2264 DO - 10.1002/path.2264 ID - Sabroe2008 ER - TY - JOUR AU - Maruyama, K. AU - Selmani, Z. AU - Ishii, K. H. AU - Yamaguchi, K. PY - 2011 DA - 2011// TI - Innate immunity and cancer therapy JO - Int Immunopharmacol VL - 11 UR - https://doi.org/10.1016/j.intimp.2010.09.012 DO - 10.1016/j.intimp.2010.09.012 ID - Maruyama2011 ER - TY - JOUR AU - Liang, X. AU - Moseman, E. A. AU - Farrar, M. A. AU - Bachanova, V. AU - Weisdorf, D. J. AU - Blazar, B. R. PY - 2010 DA - 2010// TI - Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-03-213363 DO - 10.1182/blood-2009-03-213363 ID - Liang2010 ER - TY - JOUR AU - Ren, T. AU - Xu, L. AU - Jiao, S. AU - Wang, Y. AU - Cai, Y. AU - Liang, Y. PY - 2009 DA - 2009// TI - TLR9 signaling promotes tumor progression of human lung cancer cell in vivo JO - Pathol Oncol Res VL - 15 UR - https://doi.org/10.1007/s12253-009-9162-0 DO - 10.1007/s12253-009-9162-0 ID - Ren2009 ER - TY - JOUR AU - Li, J. AU - Song, W. AU - Czerwinski, D. K. AU - Varghese, B. AU - Uematsu, S. AU - Akira, S. PY - 2007 DA - 2007// TI - Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself JO - J Immunol VL - 179 UR - https://doi.org/10.4049/jimmunol.179.4.2493 DO - 10.4049/jimmunol.179.4.2493 ID - Li2007 ER - TY - JOUR AU - Brody, J. D. AU - Ai, W. Z. AU - Czerwinski, D. K. AU - Torchia, J. A. AU - Levy, M. AU - Advani, R. H. PY - 2010 DA - 2010// TI - In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.9793 DO - 10.1200/JCO.2010.28.9793 ID - Brody2010 ER - TY - JOUR AU - Rakoff-Nahoum, S. AU - Medzhitov, R. PY - 2007 DA - 2007// TI - Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 JO - Science VL - 317 UR - https://doi.org/10.1126/science.1140488 DO - 10.1126/science.1140488 ID - Rakoff-Nahoum2007 ER - TY - JOUR AU - Swann, J. B. AU - Vesely, M. D. AU - Silva, A. AU - Sharkey, J. AU - Akira, S. AU - Schreiber, R. D. PY - 2008 DA - 2008// TI - Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis JO - Proc Natl Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0708594105 DO - 10.1073/pnas.0708594105 ID - Swann2008 ER - TY - JOUR AU - Corthals, S. L. AU - Wynne, K. AU - She, K. AU - Shimizu, H. AU - Curman, D. AU - Garbutt, K. PY - 2006 DA - 2006// TI - Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia JO - Br J Haematol VL - 132 ID - Corthals2006 ER - TY - JOUR AU - Noack, J. AU - Jordi, M. AU - Zauner, L. AU - Alessi, D. AU - Burch, A. AU - Tinguely, M. PY - 2012 DA - 2012// TI - TLR9 agonists induced cell death in Burkitt’s lymphoma cells is variable and influenced by TLR9 polymorphism JO - Cell Death Dis VL - 3 UR - https://doi.org/10.1038/cddis.2012.60 DO - 10.1038/cddis.2012.60 ID - Noack2012 ER - TY - JOUR AU - Bohnhorst, J. AU - Rasmussen, T. AU - Moen, S. H. AU - Fløttum, M. AU - Knudsen, L. AU - Børset, M. PY - 2006 DA - 2006// TI - Toll-like receptors mediate proliferation and survival of multiple myeloma cells JO - Leukemia VL - 20 UR - https://doi.org/10.1038/sj.leu.2404225 DO - 10.1038/sj.leu.2404225 ID - Bohnhorst2006 ER - TY - JOUR AU - Henault, M. AU - Lee, L. N. AU - Evans, G. F. AU - Zuckerman, S. H. PY - 2005 DA - 2005// TI - The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides JO - J Immunol Methods VL - 300 UR - https://doi.org/10.1016/j.jim.2005.02.012 DO - 10.1016/j.jim.2005.02.012 ID - Henault2005 ER - TY - JOUR AU - Buhé, V. AU - Guerrier, T. AU - Youinou, P. AU - Berthou, C. AU - Loisel, S. PY - 2009 DA - 2009// TI - CpG ODN enhances the efficacy of rituximab in non-Hodgkin lymphoma JO - Ann NY Acad Sci VL - 1173 UR - https://doi.org/10.1111/j.1749-6632.2009.04615.x DO - 10.1111/j.1749-6632.2009.04615.x ID - Buhé2009 ER - TY - JOUR AU - Akira, S. AU - Takeda, K. AU - Kaisho, T. PY - 2001 DA - 2001// TI - Toll-like receptors: critical proteins linking innate and acquired immunity JO - Nat Immunol VL - 2 UR - https://doi.org/10.1038/90609 DO - 10.1038/90609 ID - Akira2001 ER - TY - JOUR AU - Guiducci, C. AU - Ghirelli, C. AU - Marloie-Provost, M. A. AU - Matray, T. AU - Coffman, R. L. AU - Liu, Y. J. PY - 2008 DA - 2008// TI - PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation JO - J Exp Med VL - 205 UR - https://doi.org/10.1084/jem.20070763 DO - 10.1084/jem.20070763 ID - Guiducci2008 ER - TY - JOUR AU - Kumagai, Y. AU - Takeuchi, O. AU - Akira, S. PY - 2008 DA - 2008// TI - TLR9 as a key receptor for the recognition of DNA JO - Adv Drug Deliv Rev VL - 60 UR - https://doi.org/10.1016/j.addr.2007.12.004 DO - 10.1016/j.addr.2007.12.004 ID - Kumagai2008 ER - TY - JOUR AU - Honda, K. AU - Takaoka, A. AU - Taniguchi, T. PY - 2006 DA - 2006// TI - Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors JO - Immunity VL - 25 UR - https://doi.org/10.1016/j.immuni.2006.08.009 DO - 10.1016/j.immuni.2006.08.009 ID - Honda2006 ER - TY - JOUR AU - Jiang, W. AU - Lederman, M. M. AU - Harding, C. V. AU - Rodriguez, B. AU - Mohner, R. J. AU - Sieg, S. F. PY - 2007 DA - 2007// TI - TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function JO - Eur J Immunol VL - 37 UR - https://doi.org/10.1002/eji.200636984 DO - 10.1002/eji.200636984 ID - Jiang2007 ER - TY - JOUR AU - Eckl-Dorna, J. AU - Batista, F. D. PY - 2009 DA - 2009// TI - BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-10-185421 DO - 10.1182/blood-2008-10-185421 ID - Eckl-Dorna2009 ER - TY - JOUR AU - Glehn, F. AU - Santos, L. M. AU - Balashov, K. E. PY - 2012 DA - 2012// TI - Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis JO - Immunotherapy VL - 4 UR - https://doi.org/10.2217/imt.12.117 DO - 10.2217/imt.12.117 ID - Glehn2012 ER - TY - JOUR AU - Huang, X. AU - Yang, Y. PY - 2010 DA - 2010// TI - Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses JO - Expert Opin Ther Targets VL - 14 UR - https://doi.org/10.1517/14728222.2010.501333 DO - 10.1517/14728222.2010.501333 ID - Huang2010 ER - TY - JOUR AU - Peng, S. L. PY - 2005 DA - 2005// TI - Signaling in B cells via Toll-like receptors JO - Curr Opin Immunol VL - 17 UR - https://doi.org/10.1016/j.coi.2005.03.003 DO - 10.1016/j.coi.2005.03.003 ID - Peng2005 ER - TY - JOUR AU - Krieg, A. M. AU - Vollmer, J. PY - 2007 DA - 2007// TI - Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity JO - Immunol Rev VL - 220 UR - https://doi.org/10.1111/j.1600-065X.2007.00572.x DO - 10.1111/j.1600-065X.2007.00572.x ID - Krieg2007 ER - TY - JOUR AU - Gray, M. AU - Gray, D. PY - 2015 DA - 2015// TI - Regulatory B cells mediate tolerance to apoptotic self in health: implications for disease JO - Int Immunol VL - 27 UR - https://doi.org/10.1093/intimm/dxv045 DO - 10.1093/intimm/dxv045 ID - Gray2015 ER - TY - JOUR AU - Guerrier, T. AU - Pochard, P. AU - Lahiri, A. AU - Youinou, P. AU - Pers, J. O. AU - Jamin, C. PY - 2014 DA - 2014// TI - TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response JO - J Autoimmun VL - 51 UR - https://doi.org/10.1016/j.jaut.2014.02.005 DO - 10.1016/j.jaut.2014.02.005 ID - Guerrier2014 ER - TY - JOUR AU - Pasare, C. AU - Medzhitov, R. PY - 2003 DA - 2003// TI - Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells JO - Science VL - 299 UR - https://doi.org/10.1126/science.1078231 DO - 10.1126/science.1078231 ID - Pasare2003 ER - TY - JOUR AU - Yang, Y. AU - Huang, C. T. AU - Huang, X. AU - Pardoll, D. M. PY - 2004 DA - 2004// TI - Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance JO - Nat Immunol VL - 5 UR - https://doi.org/10.1038/ni1059 DO - 10.1038/ni1059 ID - Yang2004 ER - TY - JOUR AU - Conroy, H. AU - Marshall, N. A. AU - Mills, K. H. G. PY - 2008 DA - 2008// TI - TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours JO - Oncogene VL - 27 UR - https://doi.org/10.1038/sj.onc.1210910 DO - 10.1038/sj.onc.1210910 ID - Conroy2008 ER - TY - JOUR AU - Puccetti, P. PY - 2007 DA - 2007// TI - On watching the watchers: IDO and type I/II IFN JO - Eur J Immunol VL - 37 UR - https://doi.org/10.1002/eji.200737184 DO - 10.1002/eji.200737184 ID - Puccetti2007 ER - TY - JOUR AU - Duin, D. AU - Medzhitov, R. AU - Shaw, A. C. PY - 2006 DA - 2006// TI - Triggering TLR signaling in vaccination JO - Trends Immunol VL - 27 UR - https://doi.org/10.1016/j.it.2005.11.005 DO - 10.1016/j.it.2005.11.005 ID - Duin2006 ER - TY - JOUR AU - Wagner, M. AU - Poeck, H. AU - Jahrsdoerfer, B. AU - Rothenfusser, S. AU - Prell, D. AU - Bohle, B. PY - 2004 DA - 2004// TI - IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA JO - J Immunol VL - 172 UR - https://doi.org/10.4049/jimmunol.172.2.954 DO - 10.4049/jimmunol.172.2.954 ID - Wagner2004 ER - TY - JOUR AU - Morbach, H. AU - Schickel, J. N. AU - Cunningham-Rundles, C. AU - Conley, M. E. AU - Reisli, I. AU - Franco, J. L. PY - 2016 DA - 2016// TI - CD19 controls Toll-like receptor 9 responses in human B cells JO - J Allergy Clin Immunol VL - 137 UR - https://doi.org/10.1016/j.jaci.2015.08.040 DO - 10.1016/j.jaci.2015.08.040 ID - Morbach2016 ER - TY - JOUR AU - Kenny, E. F. AU - Quinn, S. R. AU - Doyle, S. L. AU - Vink, P. M. AU - Eenennaam, H. AU - O’Neill, L. A. PY - 2013 DA - 2013// TI - Bruton’s tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0074103 DO - 10.1371/journal.pone.0074103 ID - Kenny2013 ER - TY - JOUR AU - Lande, R. AU - Gilliet, M. PY - 2010 DA - 2010// TI - Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses JO - Ann NY Acad Sci VL - 1183 UR - https://doi.org/10.1111/j.1749-6632.2009.05152.x DO - 10.1111/j.1749-6632.2009.05152.x ID - Lande2010 ER - TY - JOUR AU - Carpentier, A. F. PY - 2005 DA - 2005// TI - Cancer immunotherapy with CpG-ODN JO - Med Sci (Paris). VL - 21 UR - https://doi.org/10.1051/medsci/200521173 DO - 10.1051/medsci/200521173 ID - Carpentier2005 ER - TY - JOUR AU - Verthelyi, D. AU - Ishii, K. J. AU - Gursel, M. AU - Takeshita, F. AU - Klinman, D. M. PY - 2001 DA - 2001// TI - Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs JO - J Immunol VL - 166 UR - https://doi.org/10.4049/jimmunol.166.4.2372 DO - 10.4049/jimmunol.166.4.2372 ID - Verthelyi2001 ER - TY - JOUR AU - Rothenfusser, S. AU - Tuma, E. AU - Endres, S. AU - Hartmann, G. PY - 2002 DA - 2002// TI - Plasmacytoid dendritic cells: the key to CpG JO - Hum Immunol VL - 63 UR - https://doi.org/10.1016/S0198-8859(02)00749-8 DO - 10.1016/S0198-8859(02)00749-8 ID - Rothenfusser2002 ER - TY - JOUR AU - Vollmer, J. AU - Weeratna, R. AU - Payette, P. AU - Jurk, M. AU - Schetter, C. AU - Laucht, M. PY - 2004 DA - 2004// TI - Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities JO - Eur J Immunol VL - 34 UR - https://doi.org/10.1002/eji.200324032 DO - 10.1002/eji.200324032 ID - Vollmer2004 ER - TY - JOUR AU - Mutwiri, G. K. AU - Nichani, A. K. AU - Babiuk, S. AU - Babiuk, L. A. PY - 2004 DA - 2004// TI - Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides JO - J Control Release VL - 97 UR - https://doi.org/10.1016/j.jconrel.2004.02.022 DO - 10.1016/j.jconrel.2004.02.022 ID - Mutwiri2004 ER - TY - JOUR AU - Sands, H. AU - Gorey-Feret, L. J. AU - Cocuzza, A. J. AU - Hobbs, F. W. AU - Chidester, D. AU - Trainor, G. L. PY - 1994 DA - 1994// TI - Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate JO - Mol Pharmacol VL - 45 ID - Sands1994 ER - TY - JOUR AU - Hossain, D. M. S. AU - Santos, C. AU - Zhang, Q. AU - Kozlowska, A. AU - Liu, H. AU - Gao, C. PY - 2014 DA - 2014// TI - Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-07-517987 DO - 10.1182/blood-2013-07-517987 ID - Hossain2014 ER - TY - JOUR AU - Zhang, Q. AU - Hossain, D. M. S. AU - Nechaev, S. AU - Kozlowska, A. AU - Zhang, W. AU - Liu, Y. PY - 2013 DA - 2013// TI - TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-07-442590 DO - 10.1182/blood-2012-07-442590 ID - Zhang2013 ER - TY - JOUR AU - Dorner, T. AU - Radbruch, A. PY - 2007 DA - 2007// TI - Antibodies and B cell memory in viral immunity JO - Immunity VL - 27 UR - https://doi.org/10.1016/j.immuni.2007.09.002 DO - 10.1016/j.immuni.2007.09.002 ID - Dorner2007 ER - TY - JOUR AU - Månsson, A. AU - Adner, M. AU - Höckerfelt, U. AU - Cardell, L. O. PY - 2006 DA - 2006// TI - A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation JO - Immunology VL - 118 ID - Månsson2006 ER - TY - JOUR AU - Bernasconi, N. L. AU - Onai, N. AU - Lanzavecchia, A. PY - 2003 DA - 2003// TI - A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-11-3569 DO - 10.1182/blood-2002-11-3569 ID - Bernasconi2003 ER - TY - JOUR AU - Pettengill, M. A. AU - Haren, S. D. AU - Li, N. AU - Dowling, D. J. AU - Bergelson, I. AU - Jans, J. PY - 2016 DA - 2016// TI - Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naive B cells JO - Innate Immun VL - 22 UR - https://doi.org/10.1177/1753425916651985 DO - 10.1177/1753425916651985 ID - Pettengill2016 ER - TY - JOUR AU - Yi, A. K. AU - Chang, M. AU - Peckham, D. W. AU - Krieg, A. M. AU - Ashman, R. F. PY - 1998 DA - 1998// TI - CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry JO - J Immunol. VL - 160 ID - Yi1998 ER - TY - JOUR AU - Nikitin, P. A. AU - Price, A. M. AU - McFadden, K. AU - Yan, C. M. AU - Luftig, M. A. PY - 2014 DA - 2014// TI - Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0087299 DO - 10.1371/journal.pone.0087299 ID - Nikitin2014 ER - TY - JOUR AU - Azulay-Debby, H. AU - Edry, E. AU - Melamed, D. PY - 2007 DA - 2007// TI - CpG DNA stimulates autoreactive immature B cells in the bone marrow JO - Eur J Immunol VL - 37 UR - https://doi.org/10.1002/eji.200636878 DO - 10.1002/eji.200636878 ID - Azulay-Debby2007 ER - TY - JOUR AU - Jahrsdorfer, B. AU - Mühlenhoff, L. AU - Blackwell, S. E. AU - Wagner, M. AU - Poeck, H. AU - Hartmann, E. PY - 2005 DA - 2005// TI - B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1890 DO - 10.1158/1078-0432.CCR-04-1890 ID - Jahrsdorfer2005 ER - TY - JOUR AU - Sanchez-Cuaxospa, M. AU - Contreras-Ramos, A. AU - Perez-Figueroa, E. AU - Medina-Sanson, A. AU - Jimenez-Hernandez, E. AU - Torres-Nava, J. R. PY - 2016 DA - 2016// TI - Low expression of Toll-like receptors in peripheral blood mononuclear cells of pediatric patients with acute lymphoblastic leukemia JO - Int J Oncol VL - 49 ID - Sanchez-Cuaxospa2016 ER - TY - JOUR AU - Guerrier, T. AU - Youinou, P. AU - Pers, J. O. AU - Jamin, C. PY - 2012 DA - 2012// TI - TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity JO - J Autoimmun VL - 39 UR - https://doi.org/10.1016/j.jaut.2012.05.012 DO - 10.1016/j.jaut.2012.05.012 ID - Guerrier2012 ER - TY - JOUR AU - Longo, P. G. AU - Laurenti, L. AU - Gobessi, S. AU - Petlickovski, A. AU - Pelosi, M. AU - Chiusolo, P. PY - 2007 DA - 2007// TI - The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404417 DO - 10.1038/sj.leu.2404417 ID - Longo2007 ER - TY - JOUR AU - Zent, C. S. AU - Smith, B. J. AU - Ballas, Z. K. AU - Wooldridge, J. E. AU - Link, B. K. AU - Call, T. G. PY - 2012 DA - 2012// TI - Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia JO - Leuk Lymphoma VL - 53 UR - https://doi.org/10.3109/10428194.2011.608451 DO - 10.3109/10428194.2011.608451 ID - Zent2012 ER - TY - JOUR AU - Hartmann, G. AU - Krieg, A. M. PY - 2000 DA - 2000// TI - Mechanism and function of a newly identified CpG DNA motif in human primary B cells JO - J Immunol VL - 164 UR - https://doi.org/10.4049/jimmunol.164.2.944 DO - 10.4049/jimmunol.164.2.944 ID - Hartmann2000 ER - TY - JOUR AU - Farhana, L. AU - Dawson, M. I. AU - Fontana, J. A. PY - 2005 DA - 2005// TI - Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-4124 DO - 10.1158/0008-5472.CAN-04-4124 ID - Farhana2005 ER - TY - JOUR AU - Ogata, A. AU - Chauhan, D. AU - Teoh, G. AU - Treon, S. P. AU - Urashima, M. AU - Schlossman, R. L. PY - 1997 DA - 1997// TI - IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade JO - J Immunol VL - 159 ID - Ogata1997 ER - TY - JOUR AU - Arvaniti, E. AU - Ntoufa, S. AU - Papakonstantinou, N. AU - Touloumenidou, T. AU - Laoutaris, N. AU - Anagnostopoulos, A. PY - 2011 DA - 2011// TI - Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients JO - Haematologica VL - 96 UR - https://doi.org/10.3324/haematol.2011.044792 DO - 10.3324/haematol.2011.044792 ID - Arvaniti2011 ER - TY - JOUR AU - Chatzouli, M. AU - Ntoufa, S. AU - Papakonstantinou, N. AU - Chartomatsidou, E. AU - Anagnostopoulos, A. AU - Kollia, P. PY - 2014 DA - 2014// TI - Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes JO - J Immunol VL - 192 UR - https://doi.org/10.4049/jimmunol.1302102 DO - 10.4049/jimmunol.1302102 ID - Chatzouli2014 ER - TY - JOUR AU - Mongini, P. K. AU - Gupta, R. AU - Boyle, E. AU - Nieto, J. AU - Lee, H. AU - Stein, J. PY - 2015 DA - 2015// TI - TLR-9 and IL-15 synergy promotes the in vitro clonal expansion of chronic lymphocytic leukemia B cells JO - J Immunol VL - 195 UR - https://doi.org/10.4049/jimmunol.1403189 DO - 10.4049/jimmunol.1403189 ID - Mongini2015 ER - TY - JOUR AU - Feist, M. AU - Kemper, J. AU - Taruttis, F. AU - Rehberg, T. AU - Engelmann, J. C. AU - Gronwald, W. PY - 2017 DA - 2017// TI - Synergy of interleukin 10 and Toll-like receptor 9 signalling in B cell proliferation: implications for lymphoma pathogenesis JO - Int J Cancer VL - 104 UR - https://doi.org/10.1002/ijc.30444 DO - 10.1002/ijc.30444 ID - Feist2017 ER - TY - JOUR AU - Arunkumar, N. AU - Liu, C. AU - Hang, H. AU - Song, W. PY - 2013 DA - 2013// TI - Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-kappaB activation JO - Cell Mol Immunol VL - 10 UR - https://doi.org/10.1038/cmi.2013.14 DO - 10.1038/cmi.2013.14 ID - Arunkumar2013 ER - TY - JOUR AU - Wang, J. Q. AU - Jeelall, Y. S. AU - Beutler, B. AU - Horikawa, K. AU - Goodnow, C. C. PY - 2014 DA - 2014// TI - Consequences of the recurrent MYD88 (L265P) somatic mutation for B cell tolerance JO - J Exp Med VL - 211 UR - https://doi.org/10.1084/jem.20131424 DO - 10.1084/jem.20131424 ID - Wang2014 ER - TY - JOUR AU - Ngo, V. N. AU - Young, R. M. AU - Schmitz, R. AU - Jhavar, S. AU - Xiao, W. AU - Lim, K. H. PY - 2011 DA - 2011// TI - Oncogenically active MYD88 mutations in human lymphoma JO - Nature VL - 470 UR - https://doi.org/10.1038/nature09671 DO - 10.1038/nature09671 ID - Ngo2011 ER - TY - JOUR AU - Ntoufa, S. AU - Vilia, M. G. AU - Stamatopoulos, K. AU - Ghia, P. AU - Muzio, M. PY - 2016 DA - 2016// TI - Toll-like receptors signaling: a complex network for NF-kappaB activation in B-cell lymphoid malignancies JO - Semin Cancer Biol VL - 39 UR - https://doi.org/10.1016/j.semcancer.2016.07.001 DO - 10.1016/j.semcancer.2016.07.001 ID - Ntoufa2016 ER - TY - JOUR AU - Martínez-Trillos, A. AU - Pinyol, M. AU - Navarro, A. AU - Aymerich, M. AU - Jares, P. AU - Juan, M. PY - 2014 DA - 2014// TI - Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-12-543306 DO - 10.1182/blood-2013-12-543306 ID - Martínez-Trillos2014 ER - TY - JOUR AU - Link, B. K. AU - Ballas, Z. K. AU - Weisdorf, D. AU - Wooldridge, J. E. AU - Bossler, A. D. AU - Shannon, M. PY - 2006 DA - 2006// TI - Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma JO - J Immunother VL - 29 UR - https://doi.org/10.1097/01.cji.0000211304.60126.8f DO - 10.1097/01.cji.0000211304.60126.8f ID - Link2006 ER - TY - JOUR AU - Leonard, J. P. AU - Link, B. K. AU - Emmanouilides, C. AU - Gregory, S. A. AU - Weisdorf, D. AU - Andrey, J. PY - 2007 DA - 2007// TI - Phase I trial of Toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non-Hodgkin’s lymphoma JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0815 DO - 10.1158/1078-0432.CCR-07-0815 ID - Leonard2007 ER - TY - JOUR AU - Chauhan, D. AU - Singh, A. V. AU - Brahmandam, M. AU - Carrasco, R. AU - Bandi, M. AU - Hideshima, T. PY - 2009 DA - 2009// TI - Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target JO - Cancer Cell VL - 16 UR - https://doi.org/10.1016/j.ccr.2009.08.019 DO - 10.1016/j.ccr.2009.08.019 ID - Chauhan2009 ER - TY - JOUR AU - Cottini, F. AU - Anderson, K. PY - 2015 DA - 2015// TI - Novel therapeutic targets in multiple myeloma JO - Clin Adv Hematol Oncol VL - 13 ID - Cottini2015 ER - TY - JOUR AU - Ray, A. AU - Tian, Z. AU - Das, D. S. AU - Coffman, R. L. AU - Richardson, P. AU - Chauhan, D. PY - 2014 DA - 2014// TI - A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2014.46 DO - 10.1038/leu.2014.46 ID - Ray2014 ER - TY - JOUR AU - Abdelwahed, R. B. AU - Cosette, J. AU - Donnou, S. AU - Crozet, L. AU - Ouakrim, H. AU - Fridman, W. H. PY - 2013 DA - 2013// TI - Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment JO - J Exp Clin Cancer Res VL - 32 UR - https://doi.org/10.1186/1756-9966-32-18 DO - 10.1186/1756-9966-32-18 ID - Abdelwahed2013 ER - TY - JOUR AU - Weber, J. S. AU - Zarour, H. AU - Redman, B. AU - Trefzer, U. AU - O’day, S. AU - Eertwegh, A. J. PY - 2009 DA - 2009// TI - Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24473 DO - 10.1002/cncr.24473 ID - Weber2009 ER - TY - JOUR AU - Leichman, G. AU - Gravenor, D. AU - Albert, G. AU - Schmalbach, T. PY - 2004 DA - 2004// TI - A TLR9 CpG immunomodulator in combination with chemotherapy as treatment for advanced non-small cell lung cancer (NSCLS), a randomized, controlled phase II study JO - J Clin Oncol VL - 22 ID - Leichman2004 ER - TY - JOUR AU - Jordan, M. AU - Waxman, D. J. PY - 2016 DA - 2016// TI - CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model JO - Cancer Lett VL - 373 UR - https://doi.org/10.1016/j.canlet.2015.11.029 DO - 10.1016/j.canlet.2015.11.029 ID - Jordan2016 ER - TY - JOUR AU - Jahrsdörfer, B. AU - Weiner, G. J. PY - 2008 DA - 2008// TI - CpG oligodeoxynucleotides as immunotherapy in cancer JO - Update Cancer Ther VL - 3 UR - https://doi.org/10.1016/j.uct.2007.11.003 DO - 10.1016/j.uct.2007.11.003 ID - Jahrsdörfer2008 ER - TY - JOUR AU - Mason, K. A. AU - Neal, R. AU - Hunter, N. AU - Ariga, H. AU - Ang, K. AU - Milas, L. PY - 2006 DA - 2006// TI - CpG oligodeoxynucleotides are potent enhancers of radio-and chemoresponses of murine tumors JO - Radiother Oncol VL - 80 UR - https://doi.org/10.1016/j.radonc.2006.07.024 DO - 10.1016/j.radonc.2006.07.024 ID - Mason2006 ER - TY - JOUR AU - Milas, L. AU - Mason, K. A. AU - Ariga, H. AU - Hunter, N. AU - Neal, R. AU - Valdecanas, D. PY - 2004 DA - 2004// TI - CpG oligodeoxynucleotide enhances tumor response to radiation JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0926 DO - 10.1158/0008-5472.CAN-04-0926 ID - Milas2004 ER - TY - JOUR AU - Mason, K. A. AU - Ariga, H. AU - Neal, R. AU - Valdecanas, D. AU - Hunter, N. AU - Krieg, A. M. PY - 2005 DA - 2005// TI - Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy JO - Clin Cancer Res VL - 11 ID - Mason2005 ER - TY - JOUR AU - Sohn, W. J. AU - Lee, K. W. AU - Choi, S. Y. AU - Chung, E. AU - Lee, Y. AU - Kim, T. Y. PY - 2006 DA - 2006// TI - CpG-oligodeoxynucleotide protects immune cells from γ-irradiation-induced cell death JO - Mol Immunol VL - 43 UR - https://doi.org/10.1016/j.molimm.2005.07.020 DO - 10.1016/j.molimm.2005.07.020 ID - Sohn2006 ER - TY - JOUR AU - Betting, D. J. AU - Yamada, R. E. AU - Kafi, K. AU - Said, J. AU - Rooijen, N. AU - Timmerman, J. M. PY - 2009 DA - 2009// TI - Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma JO - J Immunother VL - 32 UR - https://doi.org/10.1097/CJI.0b013e3181ab23f1 DO - 10.1097/CJI.0b013e3181ab23f1 ID - Betting2009 ER - TY - JOUR AU - Warren, T. L. AU - Dahle, C. E. AU - Weiner, G. J. PY - 2000 DA - 2000// TI - CpG oligodeoxynucleotides enhance monoclonal antibody therapy of a murine lymphoma JO - Clin Lymphoma. VL - 1 UR - https://doi.org/10.3816/CLM.2000.n.005 DO - 10.3816/CLM.2000.n.005 ID - Warren2000 ER - TY - JOUR AU - Wooldridge, J. E. AU - Ballas, Z. PY - 1997 DA - 1997// TI - KriegAM, Weiner GJ. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma JO - Blood VL - 89 ID - Wooldridge1997 ER - TY - JOUR AU - Betting, D. J. AU - Hurvitz, S. A. AU - Steward, K. K. AU - Yamada, R. E. AU - Kafi, K. AU - Rooijen, N. PY - 2012 DA - 2012// TI - Combination of cyclophosphamide, rituximab, and intratumoral CpG oligodeoxynucleotide successfully eradicates established B cell lymphoma JO - J Immunother VL - 35 UR - https://doi.org/10.1097/CJI.0b013e318261e679 DO - 10.1097/CJI.0b013e318261e679 ID - Betting2012 ER -